风湿科门诊患者对戒烟及干预措施的看法
该研究通过3个半结构化焦点小组访谈19例吸烟患者(12例类风湿关节炎、7例系统性红斑狼疮),分析其在风湿科戒烟的心理、健康、社会经济及医疗信息层面的障碍与促进因素。患者认可包含风湿病特异性教育与戒烟热线等可及资源的新戒烟方案,并将「知道为何戒烟」和「知道如何戒烟」视为戒烟进展的重要结局。
要点
- 患者常将吸烟视为应对风湿病的依靠,且极少在风湿科门诊接受戒烟咨询。
- 患者普遍不了解吸烟可加重风湿病或降低部分风湿病药物疗效。
- 设计风湿科戒烟干预时应强调风湿病健康获益并提供可及戒烟资源。
核心结论
- 患者报告的戒烟障碍与促进因素涉及心理、健康相关、社会经济及医疗信息与资源多个层面。
- 改善类风湿关节炎与系统性红斑狼疮患者戒烟照护的两个关键结局是知道为何戒烟和知道如何戒烟。
- 设计和评估风湿科戒烟干预时应强调风湿病健康获益并提供戒烟资源。
研究设计与样本
- 研究招募19例吸烟患者(12例类风湿关节炎、7例系统性红斑狼疮)参加3个半结构化焦点小组之一。
- 对焦点小组讨论转录文本采用主题分析,归类障碍、促进因素及戒烟进展标志。
主要发现
- 常见障碍包括将吸烟视为风湿病中的依靠、极少在风湿科门诊接受戒烟咨询、对吸烟加重风湿病或降低部分风湿病药物疗效的认识非常有限。
- 患者认可包含风湿病特异性教育与戒烟热线等可及资源的戒烟方案。
- 除戒烟外,患者将知道为何戒烟和如何戒烟列为优先的进展结局。
关键数值与推荐
- 原文报告仅10%的风湿科就诊记录了戒烟咨询。
- 原文报告实施使烟草戒烟热线转介增加20倍的风湿科门诊方案后开展了本研究。
临床怎么用
- 在风湿科门诊开展戒烟干预时,应结合风湿病特异性健康教育并连接戒烟热线等可及资源。
- 评估戒烟照护效果时除戒烟本身外,可关注患者是否知道为何戒烟与如何戒烟。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although smoking is a risk factor for cardiovascular and rheumatic disease severity, only 10% of rheumatology visits document cessation counseling. After implementing a rheumatology clinic protocol that increased tobacco quitline referrals 20-fold, we undertook this study to examine patients' barriers and facilitators to smoking cessation based on prior rheumatology experiences, to solicit reactions to the new cessation protocol, and to identify patient-centered outcomes or signs of cessation progress following improved care. METHODS: We recruited 19 patients who smoke (12 with rheumatoid arthritis [RA] and 7 with systemic lupus erythematosus [SLE]) to participate in 1 of 3 semistructured focus groups. Transcripts of the focus group discussions were analyzed using thematic analysis to classify barriers, facilitators, and signs of cessation progress. RESULTS: Participant-reported barriers and facilitators to cessation involved psychological, health-related, and social and economic factors, as well as health care messaging and resources. Commonly discussed barriers included viewing smoking as a crutch amid rheumatic disease, rarely receiving cessation counseling in rheumatology clinics, and very limited awareness that smoking can worsen rheumatic diseases or reduce efficacy of some rheumatic disease medications. Participants endorsed our cessation protocol with rheumatology-specific education and accessible resources, such as a quitline. Beyond quitting, participants prioritized knowing why and how to quit as signs of progress outcomes. CONCLUSION: Focus groups identified themes and categories of facilitators/barriers to smoking cessation at the levels of patient and health system. Two key outcomes of improving cessation care for patients with RA and SLE were knowing why and how to quit. Emphasizing rheumatologic health benefits and cessation resources is essential when designing and evaluating rheumatology smoking cessation interventions.
引用
- Wattiaux A, Bettendorf B, Block L, et al. Patient Perspectives on Smoking Cessation and Interventions in Rheumatology Clinics. Arthritis Care Res (Hoboken). 2020. PMID: 30768768. doi:10.1002/acr.23858
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。